| June 2022 | In a study by Robert Labes et al. insights in prevention of cyclosporine mediated anemia and peritubular capillary loss were identified.
| June 2022 | In a study by D. Abdulkhalikova et al. Endometrial Proteome changes werde identified impacted by Lifestyle modification in woman with Polycystic Ovarian Syndrome and Obesity.
| May 2022 | In a study by Maja Pušić et al. Cycle-dependent plasma protein biomarkers for peritoneal endometriosis were identified by our scioDiscover platform.
| Jan 2022 | In a study by Valentina di Pietro at Birmingham University our scioDoiscover platform was used to analyse the co-expression of proteins and microRNAs in the brains of Alzheimer's disease patients.
| Jan 2022 | Erich Piovan and collegues at University of Padua collaborated with Sciomics to study specific biomarkers in FFPE tissue samples of DLBCL patients by custom antibody microarrays.
Dr. Felix Czernilofsky
Department of Medicine V, Heidelberg University Hospital,Heidelberg, Germany
"The scioCyto assay from Sciomics was a tremendous help in characterizing complex supernatants of in vitro tumor microenvironment models. With the professional, fast and friendly support from Ronny and colleagues we were able to confirm and extend our hypotheses. I am very happy to recommend the Sciomics experience!"
Product: scioCyto
Dr. Anke König
Clinics for dermatology, venerology and allergology, University Clinics Frankfurt, Frankfurt, Germany
"We enjoyed working with Sciomics on various research projects related to inflammatory skin diseases. The cooperation with Sciomics was just excellent. In addition to processing the samples and compiling the data in a perfectly understandable way, Sciomics GmbH supports us with the entire interpretation and presentation of our results with lots of ideas beyond the usual level of corporate performance. We are looking forward to developing new ideas for further clinical studies together."
Product: scioDiscover
Thank you Harald H.H.W. Schmidt and all partners for bringing together this consortium and making this initiative p… https://t.co/SdNazVcniO
Sciomics - Enabling Precision Medicine will contribute to the initiative with its expertise and platform for protei… https://t.co/N9w228VRcF
During the next 7 years, 28 partners from 10 countries will join forces to make REPO4EU a reality and create a uniq… https://t.co/zLPRdQHR34
We are proud to be a partner in the new initiative @repo4eu selected and granted almost €23M by the EC. REPO4EU's… https://t.co/IVWuHwUqm1
RT @JPM_MDPI: Article: Antibody Arrays Identified Cycle-Dependent Plasma #Biomarker Candidates of Peritoneal #Endometriosis by Prof. Dr. Te…